Iradimed Corporation (IRMD) fundamentals score
IRADIMED CORPORATION develops, manufactures, markets and distributes Magnetic Resonance Imaging (“MRI”) compatible medical devices and related accessories, disposables and services relating to them. It was originally incorporated in Oklahoma under the name IRI Development, Inc. in 1992, and it mergeds its Oklahoma corporation into the newly formed Delaware corporation, IRADIMED CORPORATION, in April 2014.
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NASDAQ
Overall: 7.0 out of 10, Good long-term fundamentals
- Growth: 4.6/10
- Profitability: 8.7/10
- Financial health: 8.9/10
- Earnings quality: 8.7/10
- Valuation: 3.9/10
Scores are calculated from Iradimed Corporation’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10